Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 7
1981 13
1982 16
1983 8
1984 15
1985 23
1986 12
1987 16
1988 4
1989 6
1990 12
1991 6
1992 15
1993 12
1994 8
1995 3
1996 7
1997 6
1998 8
1999 6
2000 3
2001 3
2002 3
2003 5
2004 5
2005 2
2006 1
2007 2
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2015 1
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

235 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Schiller JH, et al. N Engl J Med. 2002 Jan 10;346(2):92-8. doi: 10.1056/NEJMoa011954. N Engl J Med. 2002. PMID: 11784875 Free article. Clinical Trial.
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Dewys WD, et al. Am J Med. 1980 Oct;69(4):491-7. doi: 10.1016/s0149-2918(05)80001-3. Am J Med. 1980. PMID: 7424938
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.
Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR. Edmonson JH, et al. J Clin Oncol. 1993 Jul;11(7):1269-75. doi: 10.1200/JCO.1993.11.7.1269. J Clin Oncol. 1993. PMID: 8315424 Clinical Trial.
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Kirkwood JM, et al. J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Clinical Trial.
Thymoma: current medical and surgical management.
Kesler KA, Wright CD, Loehrer PJ Sr. Kesler KA, et al. Semin Neurol. 2004 Mar;24(1):63-73. doi: 10.1055/s-2004-829588. Semin Neurol. 2004. PMID: 15229793 Review.
Thymoma and thymic carcinoma: therapeutic approaches.
Kurup A, Loehrer PJ Sr. Kurup A, et al. Clin Lung Cancer. 2004 Jul;6(1):28-32. doi: 10.3816/CLC.2004.n.018. Clin Lung Cancer. 2004. PMID: 15310414 Review.
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404).
Greenwald DR, Li H, Luger SM, Go RS, King D, Patel T, Gascoyne RD, Kolesar J, Kahl BS, Horning S. Greenwald DR, et al. J Hematol Oncol. 2013 Jul 5;6:46. doi: 10.1186/1756-8722-6-46. J Hematol Oncol. 2013. PMID: 23829878 Free PMC article. Clinical Trial.
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.
Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, Loehrer PJ Sr. Lemma GL, et al. J Clin Oncol. 2011 May 20;29(15):2060-5. doi: 10.1200/JCO.2010.32.9607. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502559 Free PMC article. Clinical Trial.
Charts for the early stopping of pilot studies.
Mehta CR, Cain KC. Mehta CR, et al. J Clin Oncol. 1984 Jun;2(6):676-82. doi: 10.1200/JCO.1984.2.6.676. J Clin Oncol. 1984. PMID: 6726306
235 results
Jump to page
Feedback